Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Active-Controlled, Multi-Center Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer: The STAAR STUDY
Conditions
Interventions
Zytiga® (Abiraterone Acetate)
SoluMatrix™ (Abiraterone Acetate)
Locations
17
United States
Alliance Research
Laguna Hills, California, United States
Tower Urology
Los Angeles, California, United States
San Bernardino Urological
San Bernardino, California, United States
Skyline Urology
Torrance, California, United States
Innovative Clinical Research Institute
Whittier, California, United States
Urology Associates, P.C.
Englewood, Colorado, United States
Start Date
March 21, 2016
Primary Completion Date
February 27, 2017
Completion Date
February 27, 2017
Last Updated
November 22, 2021
NCT07177937
NCT06594926
NCT06926283
NCT06844383
NCT05919264
NCT07004582
Lead Sponsor
Sun Pharmaceutical Industries Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions